標準簡介
FDA 510(k) 是美國醫療器材最常見的上市前提交途徑，以《聯邦食品、藥品和化妝品法案》第 510(k) 節命名。510(k) 批准證明新器材與合法上市的前置器材「實質等同」——即具有相同的預期用途和類似的技術特性，或即使不同，也不會引起新的安全性和有效性問題。由 FDA 器材和放射健康中心（CDRH）管理，510(k) 程序涵蓋大多數 II 類醫療器材和一些未豁免上市前通知的 I 類器材。每年約有 3,000-4,000 份 510(k) 提交接受審查。
510(k) 提交過程要求確定適當的前置器材，準備顯示實質等同的比較，進行性能測試（生物相容性、電磁相容性、軟體驗證等），並將材料提交給 FDA。存在三種類型的 510(k)：傳統型（最全面）、特殊型（用於充分理解的器材修改）和簡化型（利用公認的共識標準或 FDA 指南）。FDA 審查時間通常為受理後 90 天，但實際批准通常需要 3-12 個月，包括提交前交流。2023 年，FDA 推出了預定變更控制計畫途徑，允許製造商在原始提交中描述預期的器材修改，減少未來 510(k) 的需要。與 EU MDR 的主要區別包括基於前置器材的方法（而非基於風險）、通常需要較少的臨床數據，以及沒有強制性的品質系統認證——儘管預期遵守 FDA 的品質系統法規（21 CFR 820）。
Substantial Equivalence
The core of 510(k) — demonstrate your device is substantially equivalent to a legally marketed predicate device in intended use, technology, and performance.
Average 100-Day Review
FDA targets a 90-day review cycle for Traditional 510(k) submissions. Actual average clearance time is approximately 100 days, not counting RTA hold times.
Three Submission Types
Traditional 510(k) for standard comparisons, Special 510(k) for modifications to your own device, and Abbreviated 510(k) using guidance documents or special controls.
list_alt Key Submission Elements
- Predicate device comparison and substantial equivalence argument
- Device description and intended use
- Performance testing (bench, biocompatibility, software)
- Labeling including indications for use
- Sterilization validation (if applicable)
- Biocompatibility assessment per ISO 10993
- Electrical safety and EMC testing (if applicable)
- 510(k) summary or 510(k) statement
Who Needs to Comply?
Manufacturers of Class II medical devices (and some Class I and Class III devices) intended for the US market. Required before commercially distributing a new device or a device with significant changes to design or intended use.
Key Requirements
Predicate Device Selection
Identify a legally marketed predicate device with the same intended use and similar technological characteristics. The predicate must have a valid 510(k) clearance, pre-amendment status, or De Novo classification.
Substantial Equivalence Testing
Conduct performance testing to demonstrate your device is as safe and effective as the predicate. Testing scope depends on differences — may include bench testing, animal studies, biocompatibility, software validation, and/or clinical data.
Quality System Compliance
Maintain a Quality Management System compliant with 21 CFR Part 820 (Quality System Regulation). FDA may inspect your facility before or after clearance. Design controls are required for Class II devices.
Post-Market Requirements
Register your establishment and list devices with FDA annually. Report adverse events via MDR (Medical Device Reporting). Implement corrections and removals when necessary and report to FDA.
Penalties & Enforcement
Marketing a device without required 510(k) clearance is a violation of the Federal Food, Drug, and Cosmetic Act. FDA can issue Warning Letters, seize products, seek injunctions, and pursue criminal prosecution. Civil monetary penalties up to $17,730 per violation per day.